1. Home
  2. CERO vs AREB Comparison

CERO vs AREB Comparison

Compare CERO & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • AREB
  • Stock Information
  • Founded
  • CERO 2017
  • AREB 2014
  • Country
  • CERO United States
  • AREB United States
  • Employees
  • CERO N/A
  • AREB N/A
  • Industry
  • CERO
  • AREB Plastic Products
  • Sector
  • CERO
  • AREB Industrials
  • Exchange
  • CERO Nasdaq
  • AREB Nasdaq
  • Market Cap
  • CERO 9.6M
  • AREB 8.4M
  • IPO Year
  • CERO N/A
  • AREB N/A
  • Fundamental
  • Price
  • CERO $8.25
  • AREB $1.16
  • Analyst Decision
  • CERO Strong Buy
  • AREB
  • Analyst Count
  • CERO 2
  • AREB 0
  • Target Price
  • CERO $45.00
  • AREB N/A
  • AVG Volume (30 Days)
  • CERO 40.2K
  • AREB 252.1K
  • Earning Date
  • CERO 08-29-2025
  • AREB 08-12-2025
  • Dividend Yield
  • CERO N/A
  • AREB N/A
  • EPS Growth
  • CERO N/A
  • AREB N/A
  • EPS
  • CERO N/A
  • AREB N/A
  • Revenue
  • CERO N/A
  • AREB $9,474,958.00
  • Revenue This Year
  • CERO N/A
  • AREB N/A
  • Revenue Next Year
  • CERO N/A
  • AREB N/A
  • P/E Ratio
  • CERO N/A
  • AREB N/A
  • Revenue Growth
  • CERO N/A
  • AREB N/A
  • 52 Week Low
  • CERO $6.71
  • AREB $1.02
  • 52 Week High
  • CERO $895.40
  • AREB $193.48
  • Technical
  • Relative Strength Index (RSI)
  • CERO 49.24
  • AREB 39.53
  • Support Level
  • CERO $8.07
  • AREB $1.02
  • Resistance Level
  • CERO $8.90
  • AREB $1.37
  • Average True Range (ATR)
  • CERO 0.40
  • AREB 0.10
  • MACD
  • CERO 0.11
  • AREB 0.00
  • Stochastic Oscillator
  • CERO 59.38
  • AREB 40.00

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: